Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2018-10-11 (7 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: DOUARNENEZ (29100), Finistere
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE BOLOMIG : revenue, balance sheet and financial ratios
PHARMACIE BOLOMIG is a French company
founded 7 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in DOUARNENEZ (29100),
this company of category PME
shows in 2023 a net income positive of 171 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE BOLOMIG (SIREN 843007030)
Indicator
2023
2022
Revenue
N/C
N/C
Net income
171 001 €
194 955 €
EBITDA
N/C
N/C
Net margin
N/C
N/C
Revenue and income statement
In 2023, PHARMACIE BOLOMIG generates positive net income of 171 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2022-2023: 195 k€ -> 171 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
171 001 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 148%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 36%. The balance between equity and debt is satisfactory.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
147.755%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
35.781%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2022
2023
Debt ratio
206.285
147.755
Financial autonomy
28.938
35.781
Repayment capacity
None
None
Cash flow / Revenue
None%
None%
Sector positioning
Debt ratio
147.752023
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Average-5 pts over 2 years
In 2023, the debt ratio of PHARMACIE BOLOMIG (147.75) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
35.78%2023
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average+8 pts over 2 years
In 2023, the financial autonomy of PHARMACIE BOLOMIG (35.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 211.94. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
211.941
Liquidity indicators evolution PHARMACIE BOLOMIG
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2022
2023
Liquidity ratio
199.664
211.941
Interest coverage
None
None
Sector positioning
Liquidity ratio
211.942023
2022
2023
Q1: 135.23
Med: 189.76
Q3: 270.17
Good+7 pts over 2 years
In 2023, the liquidity ratio of PHARMACIE BOLOMIG (211.94) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE BOLOMIG in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of PHARMACIE BOLOMIG is estimated at
2 017 722 €
(range 1 227 073€ - 2 836 464€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
1227k€2017k€2836k€
2 017 722 €Range: 1 227 073€ - 2 836 464€
NAF 5 année 2023
Valuation method used
Net Income Multiple
171 001 €
×
11.8x
=2 017 722 €
Range: 1 227 073€ - 2 836 465€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE BOLOMIG with other companies in the same sector:
Frequently asked questions about PHARMACIE BOLOMIG
What is the revenue of PHARMACIE BOLOMIG ?
The revenue of PHARMACIE BOLOMIG is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE BOLOMIG profitable?
Yes, PHARMACIE BOLOMIG generated a net profit of 171 k€ in 2023.
Where is the headquarters of PHARMACIE BOLOMIG ?
The headquarters of PHARMACIE BOLOMIG is located in DOUARNENEZ (29100), in the department Finistere.
Where to find the tax return of PHARMACIE BOLOMIG ?
The tax return of PHARMACIE BOLOMIG is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE BOLOMIG operate?
PHARMACIE BOLOMIG operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart